CHARM Therapeutics appoints Dr Beverley Carr as Chief Business Officer
10. September 2024 07:00 ET
|
Charm Therapeutics
PRESS RELEASE CHARM Therapeutics appoints Dr Beverley Carr as Chief Business Officer Highly experienced dealmaker to lead CHARM’s business development and drive strategic value from CHARM’s...
CHARM Therapeutics appoints Dr Nicholas Edmunds as Chief Development Officer, Head of Pre-Clinical Development
30. April 2024 07:00 ET
|
Charm Therapeutics
PRESS RELEASE CHARM Therapeutics appoints Dr Nicholas Edmunds as Chief Development Officer, Head of Pre-Clinical Development LONDON – 30 April 2024 -- CHARM Therapeutics (“CHARM”, “The Company”),...
CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB)
19. März 2024 10:00 ET
|
Charm Therapeutics
PRESS RELEASE CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB) LONDON – 19 March 2024 -- CHARM Therapeutics (“CHARM”, “The Company”), a 3D deep-learning research company...
CHARM Therapeutics Strengthens Leadership Team with Key Appointments to Support Drug Discovery and Development Capability
04. Januar 2023 07:00 ET
|
Charm Therapeutics
PRESS RELEASE CHARM Therapeutics Strengthens Leadership Team with Key Appointments to Support Drug Discovery and Development Capability Enhanced leadership team brings strong AI and drug discovery...